a public good project by the
Synthesis
Company
of California

© 2026

Ruby F. Meredith | doi.page

0 works0 citations0 h-index

Ruby F. Meredith

Publications by Year

Research Areas

Radiopharmaceutical Chemistry and Applications, Head and Neck Cancer Studies, Lymphoma Diagnosis and Treatment, Monoclonal and Polyclonal Antibodies Research, Medical Imaging Techniques and Applications

Most-Cited Works

→ Phase I Study of Anti–Epidermal Growth Factor Receptor Antibody Cetuximab in Combination With Radiation Therapy in Patients With Advanced Head and Neck Cancer(2001)473 cited
→ Final report of RTOG 9610, a multi‐institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck(2007)360 cited
→ MIRD Pamphlet No. 24: Guidelines for Quantitative 131I SPECT in Dosimetry Applications(2013)330 cited
→ Factors Associated With Long-Term Dysphagia After Definitive Radiotherapy for Locally Advanced Head-and-Neck Cancer(2008)316 cited
→ Multiple Myeloma(2009)224 cited
Enhanced apoptosis with combination C225/radiation treatment serves as the impetus for clinical investigation in head and neck cancers.(2000)
→ Dosimetric Factors Associated With Long-Term Dysphagia After Definitive Radiotherapy for Squamous Cell Carcinoma of the Head and Neck

(2009)

220 cited

→ MIRD Pamphlet No. 20: The Effect of Model Assumptions on Kidney Dosimetry and Response—Implications for Radionuclide Therapy(2008)188 cited

→ Intraperitoneal Radioimmunotherapy of Ovarian Cancer with177Lu-CC49: A Phase I/II Study(1997)178 cited

→ RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck(2001)174 cited